Matin Chehelgerdi

1.4k total citations · 2 hit papers
6 papers, 864 citations indexed

About

Matin Chehelgerdi is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Matin Chehelgerdi has authored 6 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Immunology. Recurrent topics in Matin Chehelgerdi's work include CRISPR and Genetic Engineering (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Immunotherapy and Immune Responses (2 papers). Matin Chehelgerdi is often cited by papers focused on CRISPR and Genetic Engineering (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Immunotherapy and Immune Responses (2 papers). Matin Chehelgerdi collaborates with scholars based in Iran, Saudi Arabia and Germany. Matin Chehelgerdi's co-authors include Mohammad Chehelgerdi, Mohamed J. Saadh, Manimaran Vasanthan, Devendra Pratap Rao, Tamilanban Thamaraikani, Roxana Yolanda Castillo-Acobo, Renzon Daniel Cosme Pecho, Omer Qutaiba B. Allela, Reza Akhavan‐Sigari and Mabrouk A. Abo‐Zaid and has published in prestigious journals such as Molecular Cancer, Frontiers in Cell and Developmental Biology and Functional & Integrative Genomics.

In The Last Decade

Matin Chehelgerdi

6 papers receiving 849 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation

2023 552 citations Mohammad Chehelgerdi, Matin Chehelgerdi et al. Molecular Cancer profile →
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy

2024 113 citations Mohammad Chehelgerdi, Matin Chehelgerdi et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matin Chehelgerdi Iran	5	398	271	220	151	111	6	864
Sivakumar Vijayaraghavalu United States	15	542 1.4×	309 1.1×	194 0.9×	241 1.6×	66 0.6×	38	1.1k
Vijay Sagar Madamsetty United States	17	464 1.2×	359 1.3×	333 1.5×	128 0.8×	172 1.5×	31	1.1k
Xiang Gong China	13	249 0.6×	460 1.7×	217 1.0×	126 0.8×	137 1.2×	31	867
Francesco Mainini Italy	10	334 0.8×	148 0.5×	151 0.7×	81 0.5×	80 0.7×	17	697
Bilan Wang China	13	265 0.7×	248 0.9×	187 0.8×	148 1.0×	60 0.5×	18	659
Shiyan Dong China	20	744 1.9×	359 1.3×	360 1.6×	123 0.8×	75 0.7×	34	1.3k
Sadegh Dehghani Iran	15	589 1.5×	367 1.4×	127 0.6×	160 1.1×	159 1.4×	21	982
Xiao Xu China	21	615 1.5×	475 1.8×	306 1.4×	222 1.5×	123 1.1×	56	1.3k
Jingyi An China	12	254 0.6×	352 1.3×	147 0.7×	63 0.4×	135 1.2×	21	637

Countries citing papers authored by Matin Chehelgerdi

Since Specialization

Citations

This map shows the geographic impact of Matin Chehelgerdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matin Chehelgerdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matin Chehelgerdi more than expected).

Fields of papers citing papers by Matin Chehelgerdi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matin Chehelgerdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matin Chehelgerdi. The network helps show where Matin Chehelgerdi may publish in the future.

Co-authorship network of co-authors of Matin Chehelgerdi

This figure shows the co-authorship network connecting the top 25 collaborators of Matin Chehelgerdi. A scholar is included among the top collaborators of Matin Chehelgerdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matin Chehelgerdi. Matin Chehelgerdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

Abdi, N., et al.. (2025). Investigating the role of exosomal long non-coding RNAs in drug resistance within female reproductive system cancers. Frontiers in Cell and Developmental Biology. 13. 1485422–1485422. 5 indexed citations

Chehelgerdi, Mohammad, Matin Chehelgerdi, Esmaeil Mahmoudi, et al.. (2024). Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy. Molecular Cancer. 23(1). 9–9. 113 indexed citations breakdown →

Chehelgerdi, Mohammad, Matin Chehelgerdi, Omer Qutaiba B. Allela, et al.. (2023). Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Molecular Cancer. 22(1). 169–169. 552 indexed citations breakdown →

Chehelgerdi, Mohammad & Matin Chehelgerdi. (2023). The use of RNA-based treatments in the field of cancer immunotherapy. Molecular Cancer. 22(1). 106–106. 94 indexed citations

Chehelgerdi, Matin, Mohammad Chehelgerdi, Hosein Salehian-Dehkordi, et al.. (2023). Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy. Molecular Cancer. 22(1). 189–189. 96 indexed citations

Chehelgerdi, Matin, et al.. (2023). Immunoinformatic prediction of potential immunodominant epitopes from cagW in order to investigate protection against Helicobacter pylori infection based on experimental consequences. Functional & Integrative Genomics. 23(2). 107–107. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact